Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
N/A Completed N=100 Randomized Single-blind Supportive Care

Meaningful Use of Technology to Improve Health Care Delivery

Contraceptive Behavior
Source: ClinicalTrials.gov NCT01641380 ↗
Enrolled (actual)
100
Serious AEs
0.0%
Results posted
Dec 2018
Primary outcomePrimary: Appointment Adherence (Efficacy) — 34; 28 participants — p=<.05

Summary

While there have been major declines in teenage pregnancy around the country, Baltimore, Maryland has continued to experience increases over the last several years. Access and adherence to contraception has been found to be a major contributor to declines in teen pregnancy worldwide. The aim of this proof of concept pilot project is to determine preliminary efficacy of the DepoText Intervention. We will randomize urban adolescent girls who have elected Depo-Provera for ongoing contraception to receive either standard counseling and clinic appointment reminders or a text messaging (DepoTEXT) follow-up intervention. Participants in the DepoTEXT intervention will receive reminders for clinic visits and encouraging messages each month for STI prevention. The primary outcome is the preliminary efficacy for improving appointment adherence.

Outcome Measures

OutcomeResultp-value
PRIMARY
Appointment Adherence (Efficacy)		 34; 28 <.05 sig
PRIMARY
Responsiveness to Appointment Messages		 38; 34 —
SECONDARY
Proportion of Patients Satisfied With Messaging Service		 25; 24 —

Eligibility Criteria

Inclusion Criteria

  • Selected Depo-Provera for ongoing contraception
  • Have a cell phone with text messaging capacity for personal use, and
  • Agree to be randomized

Exclusion Criteria

  • Adolescent girls using other forms of contraception
  • Adolescents who do not have a cell phone w/ text messaging capability for personal use
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01641380). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search